Remote monitoring study for lung disease patients
Part of Lungs & breathing clinical trials.
This study uses remote monitoring to track patients with interstitial lung disease (ILD), a group of lung conditions. The goal is to see if monitoring from home can improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must speak English or Spanish.
- You must have been diagnosed at UCSF with one of these ILD types: Idiopathic Pulmonary Fibrosis, Chronic Hypersensitivity Pneumonitis, Connective-tissue disease related ILD, Sarcoidosis, or Familial Fibrosis.
- You must be able to provide informed consent and not be acutely ill.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to organize follow-up visits for people with interstitial lung disease (a group of lung conditions). It aims to make care simpler and more effective for patients who are already on treatment.
This study tests a learning and self-management program for people with pulmonary fibrosis. It helps you better understand and manage your lung condition.
This trial studies whether using a home monitoring program helps people with pulmonary fibrosis track their condition. It aims to make care easier and catch changes early.
This trial tests whether people with lung disease caused by a rheumatic condition can safely manage their care at home using a smartphone or tablet. It aims to see if home monitoring is as effective as in-person visits for keeping your lungs healthy.
This study tests if monitoring your vital signs remotely (like oxygen levels and heart rate) can help improve care for people who need long-term oxygen therapy due to COPD or ILD. It may help you feel more supported at home.
This study tests a home-based exercise and health coaching program for people with scarring in their lungs (fibrotic ILD). The goal is to see if doing rehab at home, with support from a coach, can help you feel better and breathe easier.
Hear when a new Fibrotic Interstitial Lung Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.